Evidence map›Paper›PMID 19139020›Full record

ArticleCancer prevention research (Philadelphia, Pa.)2009

Selenium and risk of bladder cancer: a population-based case-control study.

Kristin Wallace, Karl T Kelsey, Alan Schned, J Steven Morris, Angeline S Andrew, Margaret R Karagas

Abstract read
In one paragraph

Article in Cancer prevention research (Philadelphia, Pa.), 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 7 pooled it
5.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 7 syntheses or guidelines pooled it, 58 citations in OpenAlex.

  1. Pooled it
  2. Selenium for preventing cancer.The Cochrane database of systematic reviews · 2018
    Pooled it
  3. Pooled it
  4. Selenium for preventing cancer.The Cochrane database of systematic reviews · 2014
    Pooled it
  5. Selenium for preventing cancer.The Cochrane database of systematic reviews · 2011
    Pooled it
  6. Pooled it
  7. Selenium and bladder cancer risk: a meta-analysis.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2010
    Pooled it
  8. Trial
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Peripheral blood immune cell methylation profiles are associated with nonhematopoietic cancers.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Kristin WallaceDepartment of Community and Family Medicine, Section of Biostatistics and Epidemiology, Dartmouth Medical School, 7927 Rubin Building, 1 Medical Center Drive, Lebanon, NH 03756, USA.
Karl T Kelsey
Alan Schned
J Steven Morris
Angeline S Andrew
Margaret R Karagas
Brown University · USUniversity of Missouri · US

Funding

VARIATION IN BIOACCUMULATION AND BIOMAGNIFICATION OF METALS IN NORTHERN US LAKESP42ES007373 · NIEHS · DARTMOUTH COLLEGE · PI CHEN, CELIA Y · 1995 to 2019
$52.0M
NH CANCER REGISTRY NH COMPREHE CANCER CONTR PROG NH BREAST & CERVICAL CANCER PROGU58DP000798 · DP · NH STATE DEPT/HLTH STATISTICS/DATA MGMT · PI MONTERO, JOSE THEIR · 2007 to 2011
$12.1M
NONMELANOMA SKIN CANCER IN NEW HAMPSHIRER01CA057494 · NCI · DARTMOUTH COLLEGE · PI KARAGAS, MARGARET RITA · 1993 to 2015
$10.9M
The Molecular Epidemiology of Bladder CancerR01CA121147 · NCI · BROWN UNIVERSITY · PI KELSEY, KARL TIMOTHY · 2007 to 2010
$2.0M
Bladder Cancer Prognostic IndicatorsK07CA102327 · NCI · DARTMOUTH COLLEGE · PI ANDREW, ANGELINE SANDERSON · 2005 to 2009
$819k
NCCDPHP CDC HHS U58 DP000798NCCDPHP CDC HHS U58/DP000798NCI NIH HHS CA102327NCI NIH HHS CA121147NCI NIH HHS CA57494NCI NIH HHS K07 CA102327NCI NIH HHS R01 CA057494NCI NIH HHS R01 CA121147NIEHS NIH HHS 5 P42 ES07373NIEHS NIH HHS P42 ES007373
6 · The paper itself

Abstract

Emerging evidence indicates a potential role of selenium in the prevention of several types of cancer, including bladder cancer. We investigated the association between toenail selenium concentrations and bladder cancer risk in a population-based case-control study in New Hampshire. We analyzed data from 857 incidence cases diagnosed between July 1, 1994 and June 30, 2001 and 1,191 general population controls. Newly diagnosed cases of bladder cancer were identified from the New Hampshire State Cancer Registry, which operates a rapid reporting system. Controls were selected from population lists (driver's license and Medicare enrollment). We used logistic regression analyses to generate odds ratios (OR) and 95% confidence intervals (95% CI), controlling for age, sex, and pack-years of smoking and conducted separate analyses according to the intensity of p53 immunohistochemical staining of the tumor. Overall, toenail selenium concentrations were not significantly related to bladder cancer [OR Q4 versus Q1, 0.90 (95% CI, 0.68-1.19); P(trend) = 0.15]. However, within specific subgroups there were inverse associations, i.e., among moderate smokers [OR, 0.61 (95% CI, 0.39-0.96); P(trend) = 0.004], women [OR, 0.66 (95% CI, 0.40-1.10); P(trend) = 0.11], and those with p53-positive cancers [OR Q4 versus Q1, 0.57 (95% CI, 0.34-0.94); P(trend) = 0.01]. Our results indicate that selenium is not inversely related to risk of bladder cancer overall; however, they raise the possibility that selenium may be preventive in certain molecular phenotypes of tumors (e.g., p53 positive) or within certain subsets of a population (e.g., women or moderate smokers).

Indexed as

Case-Control StudiesFemaleHumansImmunohistochemistryMaleMiddle AgedNailsRisk FactorsSeleniumSex FactorsSmokingTumor Suppressor Protein p53Urinary Bladder NeoplasmsSeleniumTumor Suppressor Protein p53

Identifiers

PMID19139020
PMCPMC2640833
OpenAlexW2169333874

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.